Background:Triple-negative breast cancer (TNBC) is an aggressive subtype lacking estrogen receptor (ER), progesterone receptor (PR), and HER2 expression. The BRCA1 gene encodes a tumor suppressor protein critical for homologous recombination (HR) DNA repair, playing a key role in TNBC progression and treatment response. Aim: To assess BRCA1 protein expression in TNBC and evaluate its impact on survival status. Material & methods:This study retrospectively analyzed 80 TNBC cases to assess BRCA1 protein expression through immunohistochemistry and its correlation with clinicopathologic features, recurrence patterns, and survival outcomes. Kaplan-Meier survival analysis and Cox proportional hazards regression were used for statistical evaluation. Results: Findings revealed that low BRCA1 expression was significantly associated with high tumor grade, lymphovascular invasion, and poor disease-free and overall survival. Conversely, high BRCA1 expression correlated with early-stage disease, smaller tumor sizes, and improved survival outcomes. Conclusion:These results highlight the impact of low BRCA1 expression on TNBC aggressiveness and its potential role as a prognostic biomarker. Further research integrating multi-omics approaches may improve personalized treatment strategies for management of BRCA1-associated TNBC.
Amin, N., Ebrahim, N., & Hussein, M. (2025). BRCA1 in Triple-Negative Breast Cancer: A Double-Edged Sword for Prognosis and Precision Therapy. Egyptian Journal of Cancer and Biomedical Research, 9(3), 9-17. doi: 10.21608/jcbr.2025.371019.1391
MLA
Nancy H Amin; Noura A. A. Ebrahim; Mustafa A Hussein. "BRCA1 in Triple-Negative Breast Cancer: A Double-Edged Sword for Prognosis and Precision Therapy", Egyptian Journal of Cancer and Biomedical Research, 9, 3, 2025, 9-17. doi: 10.21608/jcbr.2025.371019.1391
HARVARD
Amin, N., Ebrahim, N., Hussein, M. (2025). 'BRCA1 in Triple-Negative Breast Cancer: A Double-Edged Sword for Prognosis and Precision Therapy', Egyptian Journal of Cancer and Biomedical Research, 9(3), pp. 9-17. doi: 10.21608/jcbr.2025.371019.1391
VANCOUVER
Amin, N., Ebrahim, N., Hussein, M. BRCA1 in Triple-Negative Breast Cancer: A Double-Edged Sword for Prognosis and Precision Therapy. Egyptian Journal of Cancer and Biomedical Research, 2025; 9(3): 9-17. doi: 10.21608/jcbr.2025.371019.1391